Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea

References

• Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL, Halmos G. Hypothalamic hormones and cancer. Front Neuroendocrinol 2001;22:248–291.
   PubMed Web of Science ®Google Scholar
• Reissmann T, Schally AV, Bouchard P, Riethmüller H, Hengel J. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 2000;6:322–331.
   PubMed Web of Science ®Google Scholar
• Huirne JAF, Lambalk CB. Gonadotrophin-releasing-hormone-receptor antagonists. Lancet 2001;358:1793–1803.
   PubMed Web of Science ®Google Scholar
• Halmos G, Schally AW, Pinski J, Vadillo-Buenfil M, Groot K. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LHRH) in rats by LH-RH antagonist cetrorelix. Proc Natl Acad Sci USA 1996;93:2398–2402.
   PubMed Web of Science ®Google Scholar
• Erb K, Klipping C, Duijkers I, Pechstein B, Achueler A, Hermann R. Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women. Fertil Steril 2001;75:316–323.
   Google Scholar
• Behre HM, Klein B, Steinmeyer E, McGregor G, Voigt K, Nieschlag E. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotrophin-releasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 1992;75:393–398.
   PubMed Web of Science ®Google Scholar
• Engel JB, Shally AV. Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 2007;3:157–167.
   PubMedGoogle Scholar
• Debruyne F, Bhat G, Garnick MB. Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. Future Oncol 2006;2:677–696.
   PubMedGoogle Scholar
• Han YG, Kang S, Seong JY, Geum D, Suh YH, Kim K. Negative regulation of gonadotrophin releasing hormone and gonadotrophin releasing hormone receptor gene expression by a gonadotrophin releasing homone agonist in the rat hypothalamus. J Endocrinol 1999;11:195–201.
   Google Scholar
• Li S, Pelletier G. Involvement of an autoregulatory mechanism for the regulation of gonadotrophin-releasing hormone (GnRH) gene expression in neurons in the rat preoptic area. Neurosci Lett 1994;174:61–63.
   Google Scholar
• Cho S, Han J, Sun W, Choi D, Bang Kwon H, Jarry H, Wuttke W, Kim K. Evidence for autocrine inhibition of gonadotrophin-releasing hormone (GnRH) gene transcription by GnRH in hypothalamic GT1–1 neuronal cells. Mol Brain Res 1997;50:51–58.
   PubMedGoogle Scholar
• Gianotti L, Veldhuis JD, Destefanis S, Lanfranco F, Ramunni J, Arvat E, Marzetto M, Boutignon F, Deghenghi R, Ghigo E. Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst mass. Clin Endocrinol (Oxf) 2003;59:526–532.
   Google Scholar
• Pechstein B, Nagaraja NV, Hermann R, Romeis P, Locher M, Derendorf H. Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers. J Clin Pharmacol 2000;40:266–274.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Barcena D, Vadillo-Buenfil M, Garcia-Procel E. Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, cetrorelix (SB-75). Eur J Endocrinol 1994;131:286–292.
   PubMed Web of Science ®Google Scholar
• Sommer L, Zanger K, Dyiong T, Luckhaus J, Diedrich K, Klingmuller D. Seven-day administration of the gonadotropin-releasing hormone antagonist cetrorelix in normal cycling women. Eur J Endocrinol 1994;131:280–285.
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 2009;56:729–737.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Ricchieri F, Lanzoni C, Strucchi C, Jasonni VM. Diagnostic and therapeutic approach to hypothalamic amenorrea. Ann N Y Acad Sci 2006;1092:103–113.
   PubMed Web of Science ®Google Scholar
• Berga SH, Loucks TM. Use of cognitive behaviour therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci 2006;1092:114–129.
   PubMed Web of Science ®Google Scholar
• Letterie GS, Coddington CC, Collins RL, Merriam GR. Ovulation induction using s.c. pulsatile gonadotropin releasing-hormone: effectiveness of different pulse frequencies. Hum Reprod 1996;11:19–22.
   Google Scholar
• Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in Hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999;84:1905–1911.
   PubMed Web of Science ®Google Scholar
• Miller KK, Parulekar MS, Schoenfeld E, Anderson E, Hubbard J, Klibanski A, Grinspoon SK. Decreased leptin levels in normal weight women and women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998;83:2309–2312.
   PubMed Web of Science ®Google Scholar
• Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhea and anorexia nervosa. Lancet 2005;366:74.
   PubMed Web of Science ®Google Scholar